StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN)
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s ...
ALS News Today1d
US trial of noninvasive ALS device gets green light to enroll patients
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
News Medical4d
Opioid δ-receptor agonists show promise for treating IBS-like symptoms
Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
National Academies of Sciences%2c Engineering%2c and Medicine5d
New Report Finds Co-Prescribing Opioids and Benzodiazepines to Veterans at VHA from 2007 to 2019 Increased Their Risk of Death
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
Opinion
New Castle News6dOpinion
New Castle News editorial: Naloxone availability locally an important part of fight against drug epidemic
For those in need, those locations are all in on the fight against drug overdoses. You read that correctly.
Univ. of the Pacific researchers discover possible opioid crisis breakthrough
Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.